— Know what they know.
Not Investment Advice

NEPH NASDAQ

Nephros, Inc.
1W: -12.8% 1M: -12.6% 3M: +3.9% YTD: -22.3% 1Y: -20.1% 3Y: +136.5% 5Y: -57.7%
$3.67
+0.00 (+0.00%)
 
Weekly Expected Move ±7.2%
$3 $3 $4 $4 $4
NASDAQ · Healthcare · Medical - Instruments & Supplies · Tech Score Sell · Power 38 · $39.8M mcap · 9M float · 0.208% daily turnover · Short 30% of daily vol

📊 Key Metrics

TTM
$21M
Revenue
+24.2% YoY
$2M
Net Income
+30.8% YoY
$-1M
Free Cash Flow
-133.1% YoY
66.4%
Gross Margin
20.2%
Op. Margin
19.9%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE16.1%
ROA12.4%
ROIC20.0%

Valuation

P/E22.8
P/B3.3
EV/EBITDA19.7

Leverage

Debt/Equity0.07
Current Ratio4.07
Interest Cov.1694.0x

Quality Scores

Piotroski F5/9
Altman Z-3.88
Beneish M-1.04

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms